LGND
Ligand Pharmaceuticals Incorporated
Stock
$302.96+0.22 (+0.07%)Close Oct 2, 2026
- Free cash flow, 2025
- $49M
- YoY, 2025
- −48.6%
- 5-year CAGR
- −0.5%
- 10-year CAGR
- +1.6%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $49M | −48.6% |
| 2024 | $95M | +106.8% |
| 2023 | $46M | −61.6% |
| 2022 | $120M | +71.2% |
| 2021 | $70M | +39.7% |
| 2020 | $50M | — |
| 2019 | −$32M | — |
| 2018 | $193M | +123.5% |
| 2017 | $86M | +46.8% |
| 2016 | $59M | +41.4% |
| 2015 | $42M | +102.5% |
| 2014 | $21M | +1.2% |
| 2013 | $20M | — |
| 2012 | −$434K | — |
| 2011 | −$1.3M | — |
| 2010 | −$27M | — |
| 2009 | −$34M | — |